Literature DB >> 33923053

Xanthohumol for Human Malignancies: Chemistry, Pharmacokinetics and Molecular Targets.

Vancha Harish1, Effi Haque2, Magdalena Śmiech2, Hiroaki Taniguchi2, Sarah Jamieson3, Devesh Tewari4, Anupam Bishayee3.   

Abstract

Xanthohumol (XH) is an important prenylated flavonoid that is found within the inflorescence of Humulus lupulus L. (Hop plant). XH is an important ingredient in beer and is considered a significant bioactive agent due to its diverse medicinal applications, which include anti-inflammatory, antimicrobial, antioxidant, immunomodulatory, antiviral, antifungal, antigenotoxic, antiangiogenic, and antimalarial effects as well as strong anticancer activity towards various types of cancer cells. XH acts as a wide ranging chemopreventive and anticancer agent, and its isomer, 8-prenylnaringenin, is a phytoestrogen with strong estrogenic activity. The present review focuses on the bioactivity of XH on various types of cancers and its pharmacokinetics. In this paper, we first highlight, in brief, the history and use of hops and then the chemistry and structure-activity relationship of XH. Lastly, we focus on its prominent effects and mechanisms of action on various cancers and its possible use in cancer prevention and treatment. Considering the limited number of available reviews on this subject, our goal is to provide a complete and detailed understanding of the anticancer effects of XH against different cancers.

Entities:  

Keywords:  Humulus lupulus L.; apoptosis; cancer; molecular targets; prevention; proliferation; therapy; xanthohumol

Year:  2021        PMID: 33923053     DOI: 10.3390/ijms22094478

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  103 in total

1.  Xanthohumol chalcone acts as a powerful inhibitor of carcinogenesis in drug-resistant human colon carcinoma and these effects are mediated via G2/M phase cell cycle arrest, activation of apoptotic pathways, caspase activation and targeting Ras /MEK/ERK pathway.

Authors:  Xiaokang Liu; Li Juan An; Yu Li; Yanwei Wang; Lei Zhao; Xi Lv; Jinyi Guo; Ai Lin Song
Journal:  J BUON       Date:  2019 Nov-Dec       Impact factor: 2.533

2.  Xanthohumol inhibits cell cycle progression and proliferation of larynx cancer cells in vitro.

Authors:  Adrianna Sławińska-Brych; Sylwia Katarzyna Król; Magdalena Dmoszyńska-Graniczka; Barbara Zdzisińska; Andrzej Stepulak; Mariusz Gagoś
Journal:  Chem Biol Interact       Date:  2015-08-20       Impact factor: 5.192

3.  Xanthohumol stimulates iodide uptake in rat thyroid-derived FRTL-5 cells.

Authors:  Branislav Radović; Cornelia Schmutzler; Josef Köhrle
Journal:  Mol Nutr Food Res       Date:  2005-09       Impact factor: 5.914

4.  Xanthohumol uptake and intracellular kinetics in hepatocytes, hepatic stellate cells, and intestinal cells.

Authors:  Horst Wolff; Magdalena Motyl; Claus Hellerbrand; Jörg Heilmann; Birgit Kraus
Journal:  J Agric Food Chem       Date:  2011-11-29       Impact factor: 5.279

5.  Binding of the hop (Humulus lupulus L.) chalcone xanthohumol to cytosolic proteins in Caco-2 intestinal epithelial cells.

Authors:  Yan Pang; Dejan Nikolic; Dongwei Zhu; Lucas R Chadwick; Guido F Pauli; Norman R Farnsworth; Richard B van Breemen
Journal:  Mol Nutr Food Res       Date:  2007-07       Impact factor: 5.914

Review 6.  Rucaparib: An emerging parp inhibitor for treatment of recurrent ovarian cancer.

Authors:  Angela Musella; Erlisa Bardhi; Claudia Marchetti; Laura Vertechy; Giusy Santangelo; Carolina Sassu; Federica Tomao; Francesco Rech; Renzo D'Amelio; Marco Monti; Innocenza Palaia; Ludovico Muzii; Pierluigi Benedetti Panici
Journal:  Cancer Treat Rev       Date:  2018-03-23       Impact factor: 12.111

7.  2-Hydroxychalcone and xanthohumol inhibit invasion of triple negative breast cancer cells.

Authors:  Sun Young Kim; Ik-Soo Lee; Aree Moon
Journal:  Chem Biol Interact       Date:  2013-04-03       Impact factor: 5.192

8.  Immunomodulatory activity of xanthohumol: inhibition of T cell proliferation, cell-mediated cytotoxicity and Th1 cytokine production through suppression of NF-kappaB.

Authors:  Xiaohua Gao; Dorrah Deeb; Yongbo Liu; Sarita Gautam; Scott A Dulchavsky; Subhash C Gautam
Journal:  Immunopharmacol Immunotoxicol       Date:  2009       Impact factor: 2.730

9.  Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer.

Authors:  Dan R Robinson; Shanker Kalyana-Sundaram; Yi-Mi Wu; Sunita Shankar; Xuhong Cao; Bushra Ateeq; Irfan A Asangani; Matthew Iyer; Christopher A Maher; Catherine S Grasso; Robert J Lonigro; Michael Quist; Javed Siddiqui; Rohit Mehra; Xiaojun Jing; Thomas J Giordano; Michael S Sabel; Celina G Kleer; Nallasivam Palanisamy; Rachael Natrajan; Maryou B Lambros; Jorge S Reis-Filho; Chandan Kumar-Sinha; Arul M Chinnaiyan
Journal:  Nat Med       Date:  2011-11-20       Impact factor: 53.440

10.  Xanthohumol, a Prenylated Chalcone Derived from Hops, Inhibits Growth and Metastasis of Melanoma Cells.

Authors:  Tatjana Seitz; Christina Hackl; Kim Freese; Peter Dietrich; Abdo Mahli; Reinhard Manfred Thasler; Wolfgang Erwin Thasler; Sven Arke Lang; Anja Katrin Bosserhoff; Claus Hellerbrand
Journal:  Cancers (Basel)       Date:  2021-01-29       Impact factor: 6.639

View more
  7 in total

Review 1.  Antioxidants in Hops: Bioavailability, Health Effects and Perspectives for New Products.

Authors:  Corina-Aurelia Zugravu; Roxana-Elena Bohiltea; Teodor Salmen; Elena Pogurschi; Marina Ruxandra Otelea
Journal:  Antioxidants (Basel)       Date:  2022-01-27

2.  Xanthohumol Induces ROS through NADPH Oxidase, Causes Cell Cycle Arrest and Apoptosis.

Authors:  Chun-Ming Wang; Jun Chen; Jing Zhao; Shan-Shan Hu; Shu-Qiu Zhang; Xiang-Quan Mi; Xiang Shi; Xin-Hui Cao; Zhen Li
Journal:  Oxid Med Cell Longev       Date:  2021-11-10       Impact factor: 6.543

3.  Natural Dietary Compound Xanthohumol Regulates the Gut Microbiota and Its Metabolic Profile in a Mouse Model of Alzheimer's Disease.

Authors:  Wei Liu; Kaiwu He; Desheng Wu; Li Zhou; Guowei Li; Zequn Lin; Xifei Yang; Jianjun Liu; Maggie Pui Man Hoi
Journal:  Molecules       Date:  2022-02-14       Impact factor: 4.411

4.  Ligand and Structure-Based Virtual Screening in Combination, to Evaluate Small Organic Molecules as Inhibitors for the XIAP Anti-Apoptotic Protein: The Xanthohumol Hypothesis.

Authors:  Angeliki Mavra; Christos C Petrou; Manos C Vlasiou
Journal:  Molecules       Date:  2022-07-28       Impact factor: 4.927

5.  Anticancer Potential of Xanthohumol and Isoxanthohumol Loaded into SBA-15 Mesoporous Silica Particles against B16F10 Melanoma Cells.

Authors:  Tamara Krajnović; Nebojša Đ Pantelić; Katharina Wolf; Thomas Eichhorn; Danijela Maksimović-Ivanić; Sanja Mijatović; Ludger A Wessjohann; Goran N Kaluđerović
Journal:  Materials (Basel)       Date:  2022-07-19       Impact factor: 3.748

Review 6.  Two Important Anticancer Mechanisms of Natural and Synthetic Chalcones.

Authors:  Teodora Constantinescu; Alin Grig Mihis
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

Review 7.  Modulation of Nrf2 and NF-κB Signaling Pathways by Naturally Occurring Compounds in Relation to Cancer Prevention and Therapy. Are Combinations Better Than Single Compounds?

Authors:  Violetta Krajka-Kuźniak; Wanda Baer-Dubowska
Journal:  Int J Mol Sci       Date:  2021-07-30       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.